BACKGROUND: Polypectomy rate is a surrogate quality indicator for screening colonoscopy. Various methods for identifying screening colonoscopies have been used and it is unclear how different definitions affect the estimated polypectomy rate. OBJECTIVE: To estimate polypectomy rates and how they vary according to the definition of a screening colonoscopy, using patient- and endoscopist-reported indications. METHODS: A cross-sectional analysis of endoscopists and their patients 50 to 75 years of age who underwent colonoscopy was conducted. Based on questionnaire responses, four patient indications were derived: perceived screening; perceived nonscreening; medical history indicating nonscreening; and combination of the three indications. Endoscopist indication was derived from a questionnaire completed immediately after colonoscopy. Polypectomy status was obtained from provincial physician billing records. Polypectomy rates were computed, while accounting for physician and hospital level clustering, using all four patient indications, endoscopist indication, and the agreement between patient and endoscopist indications. The effect of indications on polypectomy rate was estimated adjusting for age, sex and family history of colorectal cancer. RESULTS: A total of 2134 patients and 45 endoscopists were included. The proportion of colonoscopies classified as screening according to the nine indications ranged from 32.2% to 70.9%. Polypectomy rates ranged between 22.6% and 26.2% for screening colonoscopy, and between 27.1% and 30.8% for nonscreening colonoscopy. Adjusted ORs for indication ranged between 0.74 and 0.94. DISCUSSION: Although the proportion of colonoscopies identified as screening varied considerably among the indications, the estimated polypectomy rates were similar. CONCLUSION: The findings suggest that the way screening is defined does not greatly affect the estimates of polypectomy rate.
BACKGROUND: Polypectomy rate is a surrogate quality indicator for screening colonoscopy. Various methods for identifying screening colonoscopies have been used and it is unclear how different definitions affect the estimated polypectomy rate. OBJECTIVE: To estimate polypectomy rates and how they vary according to the definition of a screening colonoscopy, using patient- and endoscopist-reported indications. METHODS: A cross-sectional analysis of endoscopists and their patients 50 to 75 years of age who underwent colonoscopy was conducted. Based on questionnaire responses, four patient indications were derived: perceived screening; perceived nonscreening; medical history indicating nonscreening; and combination of the three indications. Endoscopist indication was derived from a questionnaire completed immediately after colonoscopy. Polypectomy status was obtained from provincial physician billing records. Polypectomy rates were computed, while accounting for physician and hospital level clustering, using all four patient indications, endoscopist indication, and the agreement between patient and endoscopist indications. The effect of indications on polypectomy rate was estimated adjusting for age, sex and family history of colorectal cancer. RESULTS: A total of 2134 patients and 45 endoscopists were included. The proportion of colonoscopies classified as screening according to the nine indications ranged from 32.2% to 70.9%. Polypectomy rates ranged between 22.6% and 26.2% for screening colonoscopy, and between 27.1% and 30.8% for nonscreening colonoscopy. Adjusted ORs for indication ranged between 0.74 and 0.94. DISCUSSION: Although the proportion of colonoscopies identified as screening varied considerably among the indications, the estimated polypectomy rates were similar. CONCLUSION: The findings suggest that the way screening is defined does not greatly affect the estimates of polypectomy rate.
Authors: Robert H Fletcher; Marion R Nadel; John I Allen; Jason A Dominitz; Douglas O Faigel; David A Johnson; Dorothy S Lane; David Lieberman; John B Pope; Michael B Potter; Deborah P Robin; Paul C Schroy; Robert A Smith Journal: J Gen Intern Med Date: 2010-08-12 Impact factor: 5.128
Authors: Maw-Soan Soon; Richard A Kozarek; Kamran Ayub; Anny Soon; Tin-Yu Lin; Otto S Lin Journal: Am J Gastroenterol Date: 2005-12 Impact factor: 10.864
Authors: Douglas K Rex; John L Petrini; Todd H Baron; Amitabh Chak; Jonathan Cohen; Stephen E Deal; Brenda Hoffman; Brian C Jacobson; Klaus Mergener; Bret T Petersen; Michael A Safdi; Douglas O Faigel; Irving M Pike Journal: Gastrointest Endosc Date: 2006-04 Impact factor: 9.427
Authors: Anna P Schenck; Carrie N Klabunde; Joan L Warren; Sharon Peacock; William W Davis; Sarah T Hawley; Michael Pignone; David F Ransohoff Journal: Cancer Epidemiol Biomarkers Prev Date: 2007-10 Impact factor: 4.254
Authors: Maida J Sewitch; Dara Stein; Lawrence Joseph; Alain Bitton; Robert J Hilsden; Linda Rabeneck; Lawrence Paszat; Jill Tinmouth; Mary Anne Cooper Journal: Can J Gastroenterol Date: 2010-11 Impact factor: 3.522
Authors: Douglas Bair; Joe Pham; M Bianca Seaton; Naveen Arya; Michelle Pryce; Trevor L Seaton Journal: Can J Gastroenterol Date: 2009-01 Impact factor: 3.522
Authors: Douglas K Rex; David A Johnson; Joseph C Anderson; Phillip S Schoenfeld; Carol A Burke; John M Inadomi Journal: Am J Gastroenterol Date: 2009-02-24 Impact factor: 10.864
Authors: Maida J Sewitch; Mengzhu Jiang; Mélanie Fon Sing; Alan Barkun; Lawrence Joseph Journal: World J Gastroenterol Date: 2014-11-21 Impact factor: 5.742